Ziwei  Wang

Dr. Ziwei Wang


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Cancer Letters
Verified
Journal Article
Closed access
WXWei Xu
Wei Xu
ZWZiwei Wang
Ziwei Wang
WZWei Zhang
Wei Zhang
KQKun Qian
Kun Qian
HLHui Li
Hui Li
YTYucheng Tang
Yucheng Tang

1 March 2018 in Genes & Diseases
Verified
Journal Article
Open access
XPXudong Peng
Xudong Peng
GLGuangyi Liu
Guangyi Liu
HPHongxia Peng
Hongxia Peng
ACAnqi Chen
Anqi Chen
LZLang Zha
Lang Zha
ZWZiwei Wang
Ziwei Wang
SOX4 is highly expressed in gastric cancer (GC) and is associated with tumor grade, metastasis and prognosis, however the mechanism is not clear. We report herein that SOX4 was upregulated and overexpression of SOX4 was associated with increased expression of the markers of Epithelial-mesenchymal transition (EMT) and stemness in clinic patient samples. In vitro, overexpression of SOX4 promoted the invasion as showed by Transwell assay and stemness of GC cells as assessed by sphere formation assay, which was suppressed by silencing SOX4 with shRNA. Further studies showed that SOX4 up-regulated the expression of EMT transcription factors Twist1, snail1 and zeb1 and stemness transcription factors SOX2 and OCT4, and promoted the nuclear translocation of β-catenin. Moreover, we revealed that TGF-β treatment significantly up-regulated the expression of SOX4 and silencing SOX4 reversed TGF-β induced invasion and sphere formation ability of GC cells. Finally, we showed that SOX4 promoted the lung metastasis and tumor formation ability of gastric cancer cells in nude mice. Our results suggest that SOX4 is a target TGF-β signaling and mediates TGF-β-induced EMT and stem cell characteristics of GC cells, revealing a novel role of TGF-β/SOX4 axis in the regulation of malignant behavior of GC.

1 January 2016 in Cancer Letters
Verified
Journal Article
Closed access
HLHui Li
Hui Li
ZWZiwei Wang
Ziwei Wang
WZWei Zhang
Wei Zhang
KQKun Qian
Kun Qian
WXWei Xu
Wei Xu
SZShouru Zhang
Shouru Zhang

21 February 2015 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
HLHui Li
Hui Li
ZWZiwei Wang
Ziwei Wang
WZWei Zhang
Wei Zhang
KQKun Qian
Kun Qian
GLGang Liao
Gang Liao
SZShouru Zhang
Shouru Zhang

31 March 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
SXShu-Sen Xia
Shu-Sen Xia
GZGuang-Jun Zhang
Guang-Jun Zhang
ZLZuo-Liang Liu
Zuo-Liang Liu
HTHong-Peng Tian
Hong-Peng Tian
YHYi He
Yi He
TZTong Zhou
Tong Zhou
MicroRNA-22 suppresses the growth, migration and invasion of colorectal cancer cells through a Sp1 negative feedback loop

1 April 2017 in Oncology Reports
Verified
Journal Article
Open access
PDF file
XTXi Tang
Xi Tang
LZLang Zha
Lang Zha
HLHui Li
Hui Li
GLGang Liao
Gang Liao
ZHZhen Huang
Zhen Huang
ZWZiwei Wang
Ziwei Wang
G protein nucleolar 3 (GNL3), a nucleolar GTP-binding protein, is highly expressed in progenitor cells, stem cells, and various types of cancer cells. Therefore, it is considered to have an important role in cancer pathogenesis. GNL3 has been reported to play crucial roles in cell proliferation, cell cycle regulation, inhibition of differentiation, ribosome biogenesis, and the maintenance of stemness, genome stability and telomere integrity. Furthermore, GNL3 has recently been shown to be involved in cancer invasion and metastasis. However, the biological significance of GNL3 in the invasion and metastasis of colon cancer remains unclear. This study was performed to address this gap in knowledge. GNL3 expression was upregulated in colon cancer tissue specimens and correlated with tumor differentiation, invasion and metastasis. GNL3 overexpression promoted cell proliferation, invasion, migration and the epithelial-mesenchymal transition (EMT) in colon cancer cells. Moreover, inhibition of the EMT and the Wnt/β‑catenin signaling pathway induced by GNL3 knockdown was partially reversed by lithium chloride (LiCl). Based on these data, GNL3 promotes the EMT in colon cancer by activating the Wnt/β‑catenin signaling pathway. In summary, GNL3 is upregulated in colon cancer and plays an important role in tumor growth, invasion and metastasis. Strategies targeting GNL3 are potential treatments for colon cancer.